NexImmune (7370) Q2 2023 Earnings Report
DE:7370 Q2 2023 EPS Results
- Actual EPS
- -EUR 6.49
- Consensus EPS
- -EUR 6.49
- Beat/Miss
- Met expectations
- One Year Ago EPS
- -EUR 15.45
DE:7370 Q2 2023 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/10/2023
- Time
- After Close
- Conference Call
- Thursday, August 10, 2023
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:7370 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Aug 07, 2024 | 2024 (Q2) | ―-1.51 | -6.49 | 76.74% (+4.98) | |
| May 13, 2024 | 2024 (Q1) | ―-2.20 | -8.28 | 73.39% (+6.08) | |
| Mar 27, 2024 | 2023 (Q4) | -5.24-4.50 | -14.55 | 69.08% (+10.05) | |
| Nov 10, 2023 | 2023 (Q3) | -5.25-210.51 | -13.43 | -1467.33% (-197.08) | |
| Aug 10, 2023 | 2023 (Q2) | -6.49-6.49 | -15.45 | 57.97% (+8.95) | |
| May 15, 2023 | 2023 (Q1) | -10.41-8.28 | -14.77 | 43.94% (+6.49) | |
| Mar 28, 2023 | 2022 (Q4) | -11.53-14.55 | -15.22 | 4.41% (+0.67) | |
| Nov 14, 2022 | 2022 (Q3) | -15.58-13.43 | -14.55 | 7.69% (+1.12) | |
| Aug 15, 2022 | 2022 (Q2) | -15.23-15.45 | -12.09 | -27.78% (-3.36) | |
| May 12, 2022 | 2022 (Q1) | -15.74-14.77 | -15.89 | 7.04% (+1.12) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
